Fred Hassan sees more consolidation in the Pharma sector.
You can see the interview here.
He claims that further consolidation is imminent because of two major factors:
1] New "Innovation Investments" require larger pools of resources. Hassan feels larger companies are better able to find drugs for complex diseases like Alzheimer's etc.
2] Smaller companies are running into cash-flow problems....and other than being acquired...these smaller companies have limited options with regards to sources of additional capital.
It is a short interview...but Hassan offers an interesting perspective in the clip.
Subscribe to:
Post Comments (Atom)
.jpg)
No comments:
Post a Comment